• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Surgery

Replacing IV catheters as needed just as effective as routine practice [The Lancet]

bys25qthea
September 23, 2012
in Surgery
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

Image: CC/raindrift

Key study points:

  1. Replacing intravenous catheters only when clinically indicated did not increase the risk of phlebitis when compared to routine replacement protocol (≤ 72-96h)
  2. Nearly 30% of IV catheters had to be replaced and failure due to occlusion, infiltration, or accidental removal was more common than phlebitis and infection.

Primer: Intravenous (IV) catheters are usually needed for extended periods of time (≥ 7 days) but  are recommended for routine replacement (72-96 hours) to decrease the risk of both infection and phlebitis. This places additional strain on the staff workload, increases health care costs, and puts the patient through another invasive procedure. The researchers aimed to show that clinically indicated IV catheter replacement was of equal benefit to routine practices (3% equivalence margin).

This [randomized] study: Investigators enrolled 3,283 patients who required catheterization and randomized them to routine catheter replacement every third day (n=1690) or to replacement as clinically indicated (n=1593). This group had their IV catheters removed only for: completion of therapy, phlebitis, occlusions, accidental removal, or suspected infection. A standard procedure was used for the preparation and insertion of IV catheters and the primary endpoint was phlebitis during catheterization or within 48 hours after catheter removal. Phlebitis was defined as two or more of the following presenting at the same time: patient reported pain or tenderness, swelling, erythema, purulent discharge, and palpable venous cord beyond catheter tip.

Phlebitis occurred in 114 patients (7%) in the clinically indicated group and an identical number of cases (114, 7%) occurred in the routine replacement group. The absolute risk difference was 0.41% (95% CI: -1.33% to 2.15%). There was an average reduction of 0.2 IV catheters per patient in the clinically indicated group. A surprising finding was the high proportion of catheter failures, about 30%  

In Sum:  Replacing IV catheters only when clinically indicated did not increase the risk of phlebitis. Also, under the clinically indicated policy, one fifth of patients can avoid an unnecessary procedure. The authors acknowledge that non-masking the research nurses could have biased the reading of phlebitis and that these results do not apply to emergency situations. With respect to the high IV catheter failure rate, the investigators noted that this is not indicative of poor outcomes at hospitals and that new research attention should focus on interventions to reduce that rate. 

RELATED REPORTS

Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab

2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

Read the full article in The Lancet

Written by AM

© 2012 2minutemedicine.com. All rights reserved. No works may be reproduced without written consent from 2minutemedicine.com. DISCALIMER: Posts are not medical advice and are not intended as such. Please see a healthcare professional if you seek medical advice.

Previous Post

Sugar-sweetened beverages and weight: not so clear [NEJM]

Next Post

Multifaceted programs to improve handover at discharge from hospital significantly improves hospital use and continuity of care [Ann Intern Med.]

RelatedReports

Biosimilar to infliximab shows equivalent safety and efficacy for treating Crohn’s disease
Chronic Disease

Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab

September 3, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]

September 3, 2025
Imatinib safe and effective as long-term treatment for chronic myeloid leukemia: The IRIS trial
Hematology

Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study

September 2, 2025
Cardiology

An absence of cardiovascular risk factors is linked to over ten additional healthy years

September 2, 2025
Next Post

Multifaceted programs to improve handover at discharge from hospital significantly improves hospital use and continuity of care [Ann Intern Med.]

Herpes zoster not significantly associated with subsequent increased incidence of cancer [CMAJ]

Surgical versus conventional therapy for weight loss treatment of obstructive sleep apnea [JAMA]

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term Outcomes of Patients with Crohn’s Disease Treated with Risankizumab
  • 2 Minute Medicine: Pharma Roundup- Obesity RNA deal, at-home Alzheimer’s dosing, oncology royalty financing, and first Bruton’s Tyrosine Kinase Inhibitor for Immune Thrombocytopenia [September 3, 2025]
  • Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.